SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-005324
Filing Date
2021-01-19
Accepted
2021-01-19 16:12:39
Documents
18
Period of Report
2021-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm213128d1_8ka.htm   iXBRL 8-K/A 54761
2 EXHIBIT 23.1 tm213128d1_ex23-1.htm EX-23.1 4061
3 EXHIBIT 99.1 tm213128d1_ex99-1.htm EX-99.1 188556
4 EXHIBIT 99.2 tm213128d1_ex99-2.htm EX-99.2 240418
5 EXHIBIT 99.3 tm213128d1_ex99-3.htm EX-99.3 120294
9 GRAPHIC image_001.jpg GRAPHIC 34129
10 GRAPHIC image_002.jpg GRAPHIC 63379
  Complete submission text file 0001104659-21-005324.txt   1115725

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20210107.xsd EX-101.SCH 3187
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20210107_lab.xml EX-101.LAB 34592
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20210107_pre.xml EX-101.PRE 22711
11 EXTRACTED XBRL INSTANCE DOCUMENT tm213128d1_8ka_htm.xml XML 3608
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35867 | Film No.: 21535622
SIC: 2834 Pharmaceutical Preparations